Literature DB >> 17086065

Persistence of a sexually transmitted highly resistant HIV-1: pol quasispecies evolution over 33 months in the absence of treatment.

Stefan Neifer1, Sybille Somogyi, Frank Schlote, Thomas Berg, Gabriele Poggensee, Claudia Kuecherer.   

Abstract

The evolution of a sexually transmitted multiresistant HIV-1 in a linked transmission chain was followed for 33 months to assess its potential to persist in the absence of treatment. The multiresistant HIV reverted slowly to wild type in reverse transcriptase (positions 44, 67, 74, 118) rendering the virus only susceptible to lamivudine/emtricitabine. Persistence of the replication-competent resistant HIV increases its potential to spread further and strengthens the importance of resistance testing in newly infected patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17086065     DOI: 10.1097/QAD.0b013e328010ac6f

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  4 in total

1.  Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa.

Authors:  Matt A Price; Carole L Wallis; Shabir Lakhi; Etienne Karita; Anatoli Kamali; Omu Anzala; Eduard J Sanders; Linda-Gail Bekker; Rogers Twesigye; Eric Hunter; Pontiano Kaleebu; Kayitesi Kayitenkore; Susan Allen; Eugene Ruzagira; Mary Mwangome; Gaudensia Mutua; Pauli N Amornkul; Gwynn Stevens; Sergei L K Pond; Malinda Schaefer; Mary A Papathanasopoulos; Wendy Stevens; Jill Gilmour
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-23       Impact factor: 2.205

2.  Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort.

Authors:  Barbara Bartmeyer; Claudia Kuecherer; Claudia Houareau; Johanna Werning; Kathrin Keeren; Sybille Somogyi; Christian Kollan; Heiko Jessen; Stephan Dupke; Osamah Hamouda
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

3.  Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity.

Authors:  Marieke Pingen; Annemarie M J Wensing; Katrien Fransen; Annelies De Bel; Dorien de Jong; Andy I M Hoepelman; Emmanouil Magiorkinis; Dimitrios Paraskevis; Maja M Lunar; Mario Poljak; Monique Nijhuis; Charles A B Boucher
Journal:  Retrovirology       Date:  2014-11-29       Impact factor: 4.602

4.  CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual.

Authors:  Djin-Ye Oh; Heiko Jessen; Claudia Kücherer; Konrad Neumann; Nari Oh; Gabriele Poggensee; Barbara Bartmeyer; Arne Jessen; Axel Pruss; Ralf R Schumann; Osamah Hamouda
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.